GURUFOCUS.COM » STOCK LIST » USA » NAS » SomaLogic Inc (NAS:SLGC) » Definitions » 14-Day RSI
Switch to:

SomaLogic 14-Day RSI

: 37.35 (As of Today)
View and export this data going back to 2021. Start your Free Trial

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2022-08-16), SomaLogic's 14-Day RSI is 37.35.

The industry rank for SomaLogic's 14-Day RSI or its related term are showing as below:

SLGC's 14-Day RSI is ranked better than
88.53% of 689 companies
in the Healthcare Providers & Services industry
Industry Median: 51.37 vs SLGC: 37.35

Competitive Comparison

For the Health Information Services subindustry, SomaLogic's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

SomaLogic 14-Day RSI Distribution

For the Healthcare Providers & Services industry and Healthcare sector, SomaLogic's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where SomaLogic's 14-Day RSI falls into.



SomaLogic  (NAS:SLGC) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SomaLogic  (NAS:SLGC) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


SomaLogic 14-Day RSI Related Terms

Thank you for viewing the detailed overview of SomaLogic's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


SomaLogic Business Description

SomaLogic logo
Traded in Other Exchanges
Address
2945 Wilderness Place, Boulder, CO, USA, 80301
SomaLogic Inc delivers precise and actionable health-management information that helps individuals to optimize their personal health and wellness throughout their lives. This information, to be provided through a global network of partners and users, is derived from SomaLogic's personalized measurement of changes in an individual's proteins over time.
Executives
Blakeman Shaun M. officer: Chief Financial Officer C/O CANTEL MEDICAL CORP. 150 CLOVE ROAD LITTLE FALLS NJ 07424
Margulies Anne H. director C/O HENRY SCHEIN, INC. 135 DURYEA ROAD MELVILLE NY 11747
Post Richard A director 998 LACOSTA LANE LANE TREE CO 80124
Casdin Eli director 1350 AVENUE OF THE AMERICAS SUITE 1140 NEW YORK NY 10019
Cox Troy director C/O FOUNDATION MEDICINE, INC. C/O FOUNDATION MEDICINE, INC., 150 SECON CAMBRIDGE MA 02141
Meisel Ted D director
Barchi Robert director
Quake Stephen director C/O FLUIDIGM CORPORATION 7000 SHORELINE COURT, SUITE 100 SOUTH SAN FRANCISCO CA 94080
Lillis Charles M. director 13 CASTLE PINES DRIVE N CASTLE ROCK CO 80108
Harris Melody officer: President and COO 4801 WEST BYRON PLACE DENVER CO 80211
Gutierrez Ruben officer: General Counsel 6435 AVENIDA WILFREDO LA JOLLA CA 92037
Graves Amy officer: Chief Accounting Officer 926 PENDLETON AVENUE LONGMONT CO 80504
Smythe Roy director, officer: Chief Executive Officer 935 10TH STREET BOULDER CO 80302
M-lsh Ii Llc 10 percent owner 667 MADISON AVENUE C/O CORVEX MANAGEMENT LP NEW YORK NY 10065
C-lsh Ii Llc 10 percent owner 1350 6TH AVENUE SUITE 2600 NEW YORK NY 10019

SomaLogic Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)